Exicure, Inc.
NCM: XCURLive Quote
About Exicure, Inc.
Healthcare
Biotechnology
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
📊 Fundamental Analysis
Exicure, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -92.5%, which indicates that capital utilization is currently under pressure.
At a current price of $3.78, XCUR currently trades near the bottom of its 52-week range (7%), indicating potential value or weakness (Range: $3.10 - $12.65).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$20.33M
Trailing P/E
--
Forward P/E
-4.91
Beta (5Y)
4.01
52W High
$12.65
52W Low
$3.10
Avg Volume
29K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App